| Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery TT Morgan, HS Muddana, EI Altinoglu, SM Rouse, A Tabakovic, ... Nano letters 8 (12), 4108-4115, 2008 | 347 | 2008 |
| Targeted Indocyanine-Green-Loaded Calcium Phosphosilicate Nanoparticles for In Vivo Photodynamic Therapy of Leukemia BM Barth, E I. Altinoğlu, SS Shanmugavelandy, JM Kaiser, ... ACS nano 5 (7), 5325-5337, 2011 | 172 | 2011 |
| Bioconjugation of Calcium Phosphosilicate Composite Nanoparticles for Selective Targeting of Human Breast and Pancreatic Cancers In Vivo BM Barth, R Sharma, EI Altınogˇlu, TT Morgan, SS Shanmugavelandy, ... ACS nano 4 (3), 1279-1287, 2010 | 156 | 2010 |
| Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia X Liu, L Ryland, J Yang, A Liao, C Aliaga, R Watts, SF Tan, J Kaiser, ... Blood, The Journal of the American Society of Hematology 116 (20), 4192-4201, 2010 | 111 | 2010 |
| Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models PP Adiseshaiah, JD Clogston, CB McLeland, J Rodriguez, TM Potter, ... Cancer letters 337 (2), 254-265, 2013 | 89 | 2013 |
| Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer Y Jiang, NA DiVittore, JM Kaiser, SS Shanmugavelandy, JL Fritz, ... Cancer biology & therapy 12 (7), 574-585, 2011 | 72 | 2011 |
| Metabolic differences in glutamine utilization lead to metabolic vulnerabilities in prostate cancer NM Zacharias, C McCullough, S Shanmugavelandy, J Lee, Y Lee, P Dutta, ... Scientific reports 7 (1), 16159, 2017 | 70 | 2017 |
| Nanoliposomal minocycline for ocular drug delivery JM Kaiser, H Imai, JK Haakenson, RM Brucklacher, TE Fox, ... Nanomedicine: Nanotechnology, Biology and Medicine 9 (1), 130-140, 2013 | 55 | 2013 |
| Ceramide–antiestrogen nanoliposomal combinations—novel impact of hormonal therapy in hormone-insensitive breast cancer SAF Morad, JC Levin, SS Shanmugavelandy, M Kester, G Fabrias, ... Molecular cancer therapeutics 11 (11), 2352-2361, 2012 | 54 | 2012 |
| C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemia LK Ryland, UA Doshi, SS Shanmugavelandy, TE Fox, C Aliaga, K Broeg, ... PLoS One 8 (12), e84648, 2013 | 50 | 2013 |
| Delivery of PAR-4 plasmid in vivo via nanoliposomes sensitizes colon tumor cells subcutaneously implanted into nude mice to 5-FU CL Kline, SS Shanmugavelandy, M Kester, RB Irby Cancer biology & therapy 8 (19), 1831-1837, 2009 | 50 | 2009 |
| Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53 SAF Morad, JP Madigan, JC Levin, N Abdelmageed, R Karimi, ... Biochemical pharmacology 85 (8), 1057-1065, 2013 | 48 | 2013 |
| Inhibition of NADPH oxidase by glucosylceramide confers chemoresistance BM Barth, SJ Gustafson, MM Young, TE Fox, SS Shanmugavelandy, ... Cancer biology & therapy 10 (11), 1126-1136, 2010 | 43 | 2010 |
| Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia RJ Watters, TE Fox, SF Tan, S Shanmugavelandy, JE Choby, K Broeg, ... Leukemia & lymphoma 54 (6), 1288-1296, 2013 | 41 | 2013 |
| PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphate BM Barth, SS Shanmugavelandy, JM Kaiser, C McGovern, EI Altınoğlu, ... ACS nano 7 (3), 2132-2144, 2013 | 39 | 2013 |
| Gaucher's disease and cancer: a sphingolipid perspective BM Barth, SS Shanmugavelandy, DM Tacelosky, M Kester, SAF Morad, ... Critical Reviews™ in Oncogenesis 18 (3), 2013 | 38 | 2013 |
| Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia BM Barth, W Wang, PT Toran, TE Fox, C Annageldiyev, RM Ondrasik, ... Blood advances 3 (17), 2598-2603, 2019 | 33 | 2019 |
| Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia N Baran, A Lodi, Y Dhungana, S Herbrich, M Collins, S Sweeney, ... Nature communications 13 (1), 2801, 2022 | 29 | 2022 |
| Selective inhibition of the second bromodomain of BET family proteins results in robust antitumor activity in preclinical models of acute myeloid leukemia L Zhang, T Cai, X Lin, X Huang, MH Bui, JP Plotnik, RJ Bellin, EJ Faivre, ... Molecular cancer therapeutics 20 (10), 1809-1819, 2021 | 23 | 2021 |
| Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In Vivo N Zacharias, J Lee, S Ramachandran, S Shanmugavelandy, J McHenry, ... Molecular Imaging and Biology 21, 86-94, 2019 | 22 | 2019 |
James H. AdairPenn State UniversityVerified email at psu.edu
